Jinyu Bio-technology Co., Ltd. (SHA:600201)

Market Cap	8.95B
Revenue (ttm)	1.26B
Net Income (ttm)	79.88M
Shares Out	1.12B
EPS (ttm)	0.07
PE Ratio	110.21
Forward PE	43.40
Dividend	0.03 (0.38%)
Ex-Dividend Date	Jun 26, 2025

Volume	19,237,378
Average Volume	33,663,964
Open	8.02
Previous Close	8.01
Day's Range	7.89 - 8.06
52-Week Range	5.62 - 8.37
Beta	0.69
RSI	62.72
Earnings Date	Aug 30, 2025

About Jinyu Bio-technology

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary products in China. Its product portfolio includes Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang animal vaccines for the prevention of foot, porcine, mycoplasma pneumoniae, porcine reproductive and respiratory syndrome, porcine pseudorabies, pathogenic avian influenza, brucellosis bacterial disease, bovine viral diarrhea and mucosal, infectious rhinotracheitis, and other domestic animal diseases. The company was founded in 1992 and i...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1992
• Employees: 1,740
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600201

Financial Performance

In 2024, Jinyu Bio-technology's revenue was 1.26 billion, a decrease of -21.45% compared to the previous year's 1.60 billion. Earnings were 108.99 million, a decrease of -61.57%.